ABSCI CORP (ABSI) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $17.00K; Additional Paid in Capital, Common StockUSD $933.56M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $150.00K.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $15.00K; Additional Paid in Capital, Common StockUSD $826.03M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $304.00K.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $15.00K; Additional Paid in Capital, Common StockUSD $813.63M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $591.00K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $15.00K; Additional Paid in Capital, Common StockUSD $805.05M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $500.00K.
ABSCI CORP Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Partners' Capital Account, Unit-based Payment Arrangement, Amount USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $17.00K | $933.56M | $150.00K | $-687.59M | $246.13M | 3 month · $4.54M | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $15.00K | $826.03M | $304.00K | $-654.38M | $171.97M | 3 month · $4.39M | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $15.00K | $813.63M | $591.00K | $-624.78M | $189.45M | 12 month · $18.29M | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $15.00K | $805.05M | $500.00K | $-595.22M | $210.34M | 3 month · $4.38M | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $13.00K | $739.57M | $311.00K | $-566.52M | $173.37M | 3 month · $4.75M | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $13.00K | $734.71M | $19.00K | $-535.95M | $198.80M | 3 month · $4.91M | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $12.00K | $688.73M | $-4.00K | $-509.60M | $179.13M | 12 month · $19.47M | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $11.00K | $681.69M | $251.00K | $-480.62M | $201.34M | 3 month · $5.49M | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $11.00K | $674.81M | $-114.00K | $-453.22M | $221.49M | 3 month · $5.35M | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $11.00K | $668.70M | $-132.00K | $-428.47M | $240.11M | 3 month · $3.54M | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $9.00K | $582.70M | $-37.00K | $-406.50M | $176.18M | 12 month · $11.38M | (m) | (m) | (m) |
| 2023-09-30 | $0.00 | $9.00K | $579.42M | $-59.00K | $-382.95M | $196.42M | 3 month · $2.54M | (m) | (m) | (m) |
| 2023-06-30 | $0.00 | $9.00K | $576.49M | $-146.00K | $-360.96M | $215.40M | 3 month · $3.04M | (m) | (m) | (m) |
| 2023-03-31 | $0.00 | $9.00K | $573.34M | $-95.00K | $-319.28M | $253.97M | 3 month · $2.65M | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | $9.00K | $570.45M | $-120.00K | $-295.93M | $274.41M | 12 month · $12.66M | (m) | (m) | (m) |
| 2022-09-30 | $0.00 | $9.00K | $569.37M | $26.00K | $-276.46M | $292.94M | 3 month · $3.76M | (m) | (m) | (m) |
| 2022-06-30 | $0.00 | $9.00K | $565.44M | $-61.00K | $-249.20M | $316.19M | 3 month · $4.20M | (m) | (m) | (m) |
| 2022-03-31 | $0.00 | $9.00K | $561.03M | $-23.00K | $-220.52M | $340.50M | 3 month · $3.68M | (m) | (m) | (m) |
| 2021-12-31 | $0.00 | $9.00K | $557.14M | $-13.00K | $-191.03M | $366.11M | 12 month · $9.93M | 12 month · $155.72M | 12 month · $4.82M | (m) |
| 2021-09-30 | $0.00 | $9.00K | $553.88M | $-15.00K | $-165.86M | $388.01M | 3 month · $3.73M | 3 month · $155.72M | 3 month · $4.82M | (m) |
| 2021-06-30 | (m) | $2.00K | $17.97M | $-11.00K | $-142.22M | $-124.26M | 3 month · $1.49M | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | $-98.50M | 3 month · $1.52M | (m) | (m) | (m) |
| 2020-12-31 | $0.00 | $2.00K | $635.00K | $0.00 | $-90.06M | $-89.43M | 12 month · $420.00K | (m) | (m) | 12 month · $-34.34M |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $86.00K | (m) | (m) | 3 month · $-9.21M |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | $-71.88M | 3 month · $58.00K | (m) | (m) | 3 month · $-13.97M |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | $-54.96M | 3 month · $8.00K | (m) | (m) | 3 month · $-11.15M |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | $-41.16M | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |